Search research articles
Contact Us
Filters
Showing results (41-50 of 94) with videos related to
Page
of 10
Sort By:
The British Journal of Surgery
|
December 3, 2022
Transfusion of salvaged red blood cells during pancreatic ductal adenocarcinoma operations
Neha Goel, Andrew D Rhim, Huaqing Xi, et al.
The Journal of Clinical Investigation
|
April 29, 2021
HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron
Rashi Singhal, Sreedhar R Mitta, Nupur K Das, et al.
Cancer Research
|
April 3, 2025
Correction: Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
Emily K W Lo, Brian M Mears, H Carlo Maurer, et al.
The Journal of Clinical Investigation
|
December 1, 2020
The vascular landscape of human cancer
Benjamin M Kahn, Alfredo Lucas, Rohan G Alur, et al.
Biorxiv : the Preprint Server for Biology
|
January 18, 2024
Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma
Alexander G Raufi, Ilenia Pellicciotta, Carmine F Palermo, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma
Maryam Safari, Luigi Scotto, Agnes Basseville, et al.
Cancer Chemotherapy and Pharmacology
|
March 25, 2011
A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy
Tashinga E Bapiro, Frances M Richards, Mae A Goldgraben, et al.
Cancer Research
|
August 21, 2020
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
Tamas A Gonda, Jarwei Fang, Martha Salas, et al.
Cancer Research
|
September 17, 2005
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development
Susan W P Wijnhoven, Edwin Zwart, Ewoud N Speksnijder, et al.
Gastroenterology
|
September 4, 2013
Identification and manipulation of biliary metaplasia in pancreatic tumors
Kathleen E Delgiorno, Jason C Hall, Kenneth K Takeuchi, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 94) with videos related to
Sort By:
Page
of 10
The British Journal of Surgery
|
December 3, 2022
Transfusion of salvaged red blood cells during pancreatic ductal adenocarcinoma operations
Neha Goel, Andrew D Rhim, Huaqing Xi, et al.
The Journal of Clinical Investigation
|
April 29, 2021
HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron
Rashi Singhal, Sreedhar R Mitta, Nupur K Das, et al.
Cancer Research
|
April 3, 2025
Correction: Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
Emily K W Lo, Brian M Mears, H Carlo Maurer, et al.
The Journal of Clinical Investigation
|
December 1, 2020
The vascular landscape of human cancer
Benjamin M Kahn, Alfredo Lucas, Rohan G Alur, et al.
Biorxiv : the Preprint Server for Biology
|
January 18, 2024
Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma
Alexander G Raufi, Ilenia Pellicciotta, Carmine F Palermo, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma
Maryam Safari, Luigi Scotto, Agnes Basseville, et al.
Cancer Chemotherapy and Pharmacology
|
March 25, 2011
A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy
Tashinga E Bapiro, Frances M Richards, Mae A Goldgraben, et al.
Cancer Research
|
August 21, 2020
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
Tamas A Gonda, Jarwei Fang, Martha Salas, et al.
Cancer Research
|
September 17, 2005
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development
Susan W P Wijnhoven, Edwin Zwart, Ewoud N Speksnijder, et al.
Gastroenterology
|
September 4, 2013
Identification and manipulation of biliary metaplasia in pancreatic tumors
Kathleen E Delgiorno, Jason C Hall, Kenneth K Takeuchi, et al.
Page
of 10